These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22081358

  • 1. Personalized medicine: changing the paradigm of drug development.
    Couch RD, Mott BT.
    Methods Mol Biol; 2012; 823():367-78. PubMed ID: 22081358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A challenging drug development process in the era of personalized medicine.
    Jørgensen JT.
    Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
    [Abstract] [Full Text] [Related]

  • 5. Toward personalized medicine in the neuropsychiatric field.
    Wong EH, Fox JC, Ng MY, Lee CM.
    Int Rev Neurobiol; 2011 Oct; 101():329-49. PubMed ID: 22050858
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacogenetics and personalized medicine: the future for drug prescribing.
    Mitri Z, Esmerian MO, Simaan JA, Sabra R, Zgheib NK.
    J Med Liban; 2010 Oct; 58(2):101-4. PubMed ID: 20549897
    [Abstract] [Full Text] [Related]

  • 9. Heart failure and personalized medicine.
    Mestroni L, Merlo M, Taylor MR, Camerini F, Sinagra G.
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):6-12. PubMed ID: 20814312
    [Abstract] [Full Text] [Related]

  • 10. Progress towards personalized medicine.
    Bates S.
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Front-line drug discovery system for cancer].
    Mizukami T.
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [Abstract] [Full Text] [Related]

  • 14. Nanobiotechnology and personalized medicine.
    Jain KK.
    Prog Mol Biol Transl Sci; 2011 Dec; 104():325-54. PubMed ID: 22093223
    [Abstract] [Full Text] [Related]

  • 15. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J.
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HLA, immunogenetics, pharmacogenetics and personalized medicine.
    Charron D.
    Vox Sang; 2011 Jan; 100(1):163-6. PubMed ID: 21175666
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.